Ontario is Canada's largest cannabis market by a wide margin: 441 million grams sold for $2.28 billion in 2025 through 1,780 authorized stores at year-end. The Ontario Cannabis Store (OCS) is a third structural variant in this series. Unlike Alberta's private retail (wholesaled
BC runs a hybrid model: the Liquor Distribution Branch (LDB) is the government wholesale distributor, the same role Alberta's AGLC plays, but LDB also operates 39 government-run BC Cannabis Stores directly, the retail role Quebec's SQDC plays exclusively, while simultaneously wholesaling to roughly 512 other
Alberta runs a private retail model for non-medical cannabis — AGLC licenses and wholesales to independent stores, rather than operating them directly the way Quebec's SQDC does. In fiscal 2024-25 (year ended March 31, 2025), AGLC moved 182,442 kg of dried-cannabis-equivalent product through 713
Alabama legalized medical cannabis in 2021. Litigation over the licensing process delayed actual sales for five years — the state's first dispensary, Callie's Apothecary in Montgomery, opened June 3-4, 2026. A second location opened in Talladega on August 28. The program allows no flower, no smoking,
Texas ran a medical cannabis program more restrictive than comparator states for a decade: three dispensing organizations, all in central Texas, selling mostly edibles, tinctures, and beverages capped at 0.5–1% THC by weight, with no overnight product storage allowed outside the home dispensary. A 2024 state-commissioned evaluation
Georgia's medical cannabis program spent years capped at 5% THC, with no smokable or vaporizable flower allowed. On July 1, 2026, that changed — GMCC says the new products are available at both dispensaries and independent pharmacies, though how consistently that's playing out at the pharmacy counter
Kentucky doesn't publish a revenue dashboard, but the real number exists — it surfaced in legislative testimony instead. OMC told the state legislature on July 2 that Kentucky had shipped $4.4 million worth of product to dispensaries as of June 11 — a wholesale figure, corrected here to roughly
Before Delaware's adult-use launch, Marijuana Commissioner Rob Coupe projected the state's legal cannabis market would reach $281 million in its first year — extrapolating existing medical patient spending (about $3,303/year per patient) across an estimated 85,000 future customers. Actual first-year sales came
New Hampshire's therapeutic cannabis program enrolled 16,846 patients as of June 2025 — up 14.6% in a single year, its strongest growth since the 2018–2020 expansion phase — served by three nonprofit operators holding four statutory Alternative Treatment Center certificates across seven dispensing locations. RSA 126-X:
South Dakota and North Dakota are, for cannabis-policy purposes, close to a matched pair: nearly identical Republican supermajorities, nearly identical median income and education, nearly identical rejection of adult-use legalization, and populations within 17% of each other. South Dakota's medical program still enrolls roughly double North
North Dakota's medical marijuana program sold $22.4 million in fiscal year 2024 through eight dispensaries supplied by exactly two manufacturers — the maximums state law permits without a regulatory finding that has never been made. Under the framework's assumptions, the legal channel captures roughly 11% of
Iowans spend an estimated three-quarters of a billion dollars a year on cannabis. About $13.7 million of it — 1.8% — passes through the state's five licensed dispensaries. The rest, roughly $760 million annually — about $2.1 million every day — is spending Iowa's medical channel